Eade Katherine A.
Transaction: 06/09/2026
BUY
Change
+16,556
Price
Not reported
Filing
06/12/2026
Type
BUY
Harvard Bioscience, Inc.
HBIO • Medical - Instruments & Supplies
$8.02
▲ +0.02 (+0.25%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$27.83M
Growth
-0.4%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 1.26Healthy liquidity · 2.2High debt level · 3.22Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:24 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.02
Change0.25%
Market Cap$27.83M
52W Range3.80 - 9.40
Beta1.49
Gross Margin53.01%
Oper. Margin-0.73%
Profit Margin-65.51%
Debt/Eq3.22
Current Ratio2.20
Quick Ratio1.25
Revenue 5Y-0.40%
Price$8.02
Change0.25%
Market Cap$27.83M
52W Range3.80 - 9.40
Beta1.49
Gross Margin53.01%
Oper. Margin-0.73%
Profit Margin-65.51%
Debt/Eq3.22
Current Ratio2.20
Quick Ratio1.25
Revenue 5Y-0.40%
Target$6.00
Target Upside-25.19%
Target Median$6.00
Target Range6.00 - 6.00
Volume21.41K
Avg Volume22.13K
EPS Surprise0.29
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
54/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Positive free cash flow · 1.26Healthy liquidity · 2.2High debt level · 3.22Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Benson Seth Benjamin
Transaction: 06/09/2026
BUY
Change
+16,556
Price
Not reported
Filing
06/11/2026
Type
BUY
Gagnon Robert E.
Transaction: 06/09/2026
BUY
Change
+16,556
Price
Not reported
Filing
06/11/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Eade Katherine A. | BUY | +16,556 | Not reported | 06/09/2026 | 06/12/2026 |
| Benson Seth Benjamin | BUY | +16,556 | Not reported | 06/09/2026 | 06/11/2026 |
| Gagnon Robert E. | BUY | +16,556 | Not reported | 06/09/2026 | 06/11/2026 |
| DENELSKY STEPHEN J | BUY | +16,556 | Not reported | 06/09/2026 | 06/11/2026 |
| Snider William | BUY | +16,556 | Not reported | 06/09/2026 | 06/11/2026 |
| Frost Mark T | BUY | +30,000 | Not reported | 03/20/2026 | 04/01/2026 |
| Frost Mark T | BUY | +5,000 | $5.00 | 03/16/2026 | 04/01/2026 |
| Duke John D | BUY | +75,000 | Not reported | 03/20/2026 | 03/23/2026 |
| Snider William | BUY | +8,475 | $4.85 | 03/17/2026 | 03/18/2026 |
| DENELSKY STEPHEN J | BUY | +10,000 | $4.87 | 03/17/2026 | 03/18/2026 |
| Snider William | BUY | +12,525 | $4.99 | 03/16/2026 | 03/18/2026 |
| Duke John D | BUY | +5,000 | $5.01 | 03/16/2026 | 03/17/2026 |
| Snider William | OTHER | +600,000 | $0.50 | 12/17/2025 | 12/30/2025 |
| Snider William | BUY | +110,000 | Not reported | 12/17/2025 | 12/30/2025 |
| DENELSKY STEPHEN J | OTHER | 0 | Not reported | 09/05/2025 | 10/07/2025 |
| DENELSKY STEPHEN J | BUY | +110,000 | Not reported | 09/05/2025 | 10/07/2025 |
| Green James W | SELL | -113,366 | Not reported | 08/15/2025 | 08/19/2025 |
| Duke John D | BUY | +500,000 | Not reported | 08/08/2025 | 08/11/2025 |
| Benson Seth Benjamin | OTHER | 0 | Not reported | 07/16/2025 | 07/25/2025 |
| Benson Seth Benjamin | BUY | +110,000 | Not reported | 07/16/2025 | 07/25/2025 |